25,188 results on '"Immunotherapy"'
Search Results
2. New Inflammatory Bowel Disease Study Findings Recently Were Reported by Researchers at Taichung Veterans General Hospital [Real-world Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease In Taiwan: a Prospective...].
3. Efficient multiplex non-viral engineering and expansion of polyclonal gd CAR-T cells for immunotherapy (Updated October 15, 2024).
4. Harbin Medical University Cancer Hospital Researchers Provide New Data on Gastric Cancer (Integrin b5, a noninvasive diagnostic biomarker, is associated with unfavorable prognosis and immunotherapy efficacy in gastric cancer).
5. Studies in the Area of Cancer Reported from University of Bayreuth (Immunomodulatory Properties of Hdac6 Inhibitors In Cancer Diseases: New Chances for Sophisticated Drug Design and Treatment Optimization).
6. Study Findings on Nanocapsules Detailed by Researchers at San Raffaele Roma Open University [Biocompatible Poly(e-Caprolactone) Nanocapsules Enhance the Bioavailability, Antibacterial, and Immunomodulatory Activities of Curcumin].
7. A novel prediction model for immunotherapy induced pneumonitis prediction based on Chest CT and electronic health record.
8. A Phase II Trial of Lovastatin and Pembrolizumab in Patients with RM HNSCC (LAPP).
9. Targeting ZNF638 activates antiviral immune responses and potentiates immune checkpoint inhibition in glioblastoma.
10. Similar Efficacy, Safety, and Immunogenicity of FYB206 in Comparison to Keytruda as add-on to Chemotherapy in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC).
11. Bridging the Gap in Immunotherapy Prediction: The AGAE Score as a Pan Cancer Biomarker for Immune Checkpoint Inhibitor Response.
12. A CXCR4 partial agonist improves immunotherapy by targeting polymorphonuclear myeloid-derived suppressor cells and cancer-driven granulopoiesis.
13. Sensory Evaluation of Taste and Smell in Oncology.
14. Reversing Immunosenescence with Senolytics to Enhance Tumor Immunotherapy.
15. Regulating Human T Lymphocytes Through Magnetogenetic Tools.
16. Efficacy and Safety of Autologous Tumor-Infiltrating Lymphocytes (TIL) Therapy Combined With Pembrolizumab Immunotherapy in Patients With Advanced Brain Cancer Including Gliomas and Meningiomas.
17. Patent Application Titled "Biomarkers for Therapy Response After Immunotherapy" Published Online (USPTO 20240336971).
18. Patent Issued for Neutralizing antibodies to the avb8 integrin complex for immunotherapy (USPTO 12110334).
19. Patent Issued for Manipulating ARID5B expression in immune cells to promote metabolism, survival, and function (USPTO 12109236).
20. Patent Issued for Modulating gabarap to modulate immunogenic cell death (USPTO 12109266).
21. Patent Issued for Compositions of programmed death receptor 1 (PD-1) antibodies and methods of obtaining the compositions thereof (USPTO 12110330).
22. Department of Gynecology Researchers Release New Study Findings on Ovarian Cancer (Investigating PPT2's role in ovarian cancer prognosis and immunotherapy outcomes).
23. Findings from Fujian Medical University in Liposomes Reported (Reprogramming the Tumor Immune Microenvironment Through Activatable Photothermal Therapy and Gsh Depletion Using Liposomal Gold Nanocages To Potentiate Anti-metastatic Immunotherapy).
24. Study Results from Western Michigan University in the Area of Personalized Medicine Reported (Advancements and Challenges In Personalized Therapy for braf-mutant Melanoma: a Comprehensive Review).
25. Study Results from Miami Cancer Institute Provide New Insights into Head and Neck Cancer (A Review of Immunotherapy for Head and Neck Cancer).
26. Reports Outline Amyloidosis Study Results from Damascus University (Secondary amyloidosis treated with tocilizumab as a complication of temporal arteritis).
27. New Multiple Myeloma Findings from Alborz University of Medical Sciences Published (Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy).
28. Fudan University Researcher Publishes New Study Findings on Membranous Nephropathy (Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy).
29. New Food Allergies Research Reported from Sant'Andrea University Hospital (Probiotics and other adjuvants in allergen-specific immunotherapy for food allergy: a comprehensive review).
30. New Findings from Sichuan University in the Area of Pancreatic Cancer Described (Consensus, debate, and prospective on pancreatic cancer treatments).
31. Study Findings on Multiple Sclerosis Reported by a Researcher at University Hospital Basel (Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13...).
32. Findings on Nanoparticles Discussed by Investigators at Beijing University of Chemical Technology (A Nir-ii Organic Dendrimer With Superb Photothermal Performance Based On Electron-donor Iteration for Photothermal Immunotherapy).
33. Nanjing Tongren Hospital Researchers Report on Findings in Allergic Rhinitis (Effect of mite-specific subcutaneous immunotherapy on patients with allergic rhinitis).
34. Reports from Nankai University Provide New Insights into Rheumatoid Arthritis (Microenvironment-activatable Probe for Precise Nir-ii Monitoring and Synergistic Immunotherapy In Rheumatoid Arthritis).
35. New Squamous Cell Carcinoma Findings from Nanjing University Medical School Described (Integrating clinical and genomic landscape analysis of perineural invasion identify ACTA1 as an oncogene for oral squamous cell carcinoma).
36. Research from Southern Medical University Yields New Study Findings on Bladder Cancer (Identification of RNA-binding protein RBMS3 as a potential biomarker for immunotherapy in bladder cancer).
37. Studies from Jagiellonian University Medical College Have Provided New Data on Chronic Lymphocytic Leukemia (Comparative safety of novel targeted therapies in relapsed/refractory chronic lymphocytic leukemia: a network meta-analysis).
38. Studies from American University of Beirut Further Understanding of Squamous Cell Carcinoma (Case report: Neoadjuvant-intent pembrolizumab resulted in complete response in a xeroderma pigmentosum patient with locally advanced resectable...).
39. Research Results from Hiroshima University Hospital Update Knowledge of Non-Small Cell Lung Cancer (A Case of Granulocyte-Colony-Stimulating Factor-Producing Non-Small Cell Lung Cancer under Steroid Treatment and with Poor Performance Status...).
40. New Non-Small Cell Lung Cancer Study Findings Reported from Cancer Hospital (Spatial analyses revealed S100P + TFF1 + tumor cells in spread through air spaces samples correlated with undesirable therapy response in non-small cell lung cancer).
41. New Findings from University Hospital Nantes in the Area of Type 3 von Willebrand Disease Described (Bleeding management in type 3 von Willebrand disease with anti-von Willebrand factor inhibitor: A literature review and case report).
42. Findings from Hiroshima University Provides New Data about Monoclonal Antibodies (Pembrolizumab-associated Neuronopathy With Improved Lower Limb Somatosensory Evoked Potential After Intravenous Methylprednisolone Treatment: a Case Report).
43. Study Results from Beijing University of Chemical Technology Provide New Insights into Necroptosis (Induced Necroptosis and Its Role in Cancer Immunotherapy).
44. New Liver Cancer Study Findings Recently Were Reported by Researchers at Fukushima Medical University (A Case of Patient With Atezolizumab-induced Encephalitis In Hepatocellular Carcinoma).
45. New Mesotheliomas Study Findings Have Been Published by a Researcher at University Hospitals Seidman Cancer Center (Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies).
46. Reports from Tianjin Medical University Cancer Institute and Hospital Describe Recent Advances in Chronic Lymphocytic Leukemia (Comparing the Efficacy and Safety of First-Line Treatments for Chronic Lymphocytic Leukemia: A Network Meta-Analysis).
47. Research from Hangzhou Medical College in the Area of Carcinomas Published [The prognostic value and immunological role of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) in pan-cancer study].
48. Data from University of Macau Provide New Insights into Cancer (A Robust Ros Generation and Ferroptotic Lipid Modulation Nanosystem for Mutual Reinforcement of Ferroptosis and Cancer Immunotherapy).
49. Research on Biologics Discussed by Researchers at Yeungnam University College of Medicine (Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins).
50. New Findings from National Clinical Research Center for Cancer in the Area of Squamous Cell Carcinoma Published (Integrative multi-omic and machine learning approach for prognostic stratification and therapeutic targeting in lung squamous cell...).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.